國元證券(000728.SZ):2020年度第五期短期融資券將於11月19日兑付
格隆匯 11 月 11日丨國元證券(000728.SZ)公佈,為保證國元證券股份有限公司2020年度第五期短期融資券兑付工作的順利進行,方便投資者及時領取兑付資金,現將有關事宜公告如下:一、本期債券基本情況
1.發行人:國元證券股份有限公司
2.債券名稱:國元證券股份有限公司2020年度第五期短期融資券
3.債券簡稱:20國元證券CP005
4.債券代碼:072000213
5.發行總額:人民幣20億元
6.債券期限:90天
7.本計息期債券利率:2.73%
8.還本付息方式:利隨本清
9.兑付日:2020年11月19日(遇節假日順延至下一工作日)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.